The trademark application LENIRAX was filed by ROYDERMAL LABORATOIRE PHARMACEUTIQUE S.R.L., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on May 23, 2022, and it was registered by office on August 30, 2022 without any oppositions.
The application was filed in Italian (English was selected as the second language).